HOME >> BIOLOGY >> NEWS
Hemophilia therapy update: New information on investigational Factor VIII therapy development

WEBCAST INVITATION

Hemophilia Therapy Update: New Information on Investigational Factor VIII Therapy Development

Monday, December 9, 2002
12:30 1:30 EST
Loews Philadelphia Hotel, Commonwealth Hall A

AGENDA

Understanding Treatment Choices A Father's Perspective
Joe Caronna, Vice President, New Jersey Hemophilia Association, and Father of Patient with Hemophilia A

The Current Hemophilia Treatment Landscape
W. Keith Hoots, M.D., Medical Director, Gulf States Hemophilia and Thrombophilia Center, Houston, Texas

Phase II-III Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) Clinical Trial Data
Peter Collins, M.D., M.R.C.P., Director, Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, Wales

New Developments in Recombinant Factor VIII Technology
Edward D. Gomperts, M.D., Global Vice President, Medical Affairs, Baxter BioScience

Moderator: Edward D. Gomperts, M.D.

To register for the live webcast, please enter the newsroom of Baxter.com (http://www.baxter.com) and click on the "Hemophilia Therapy Update Webcast" button.

To R.SV.P. for the briefing or to receive additional information, please contact:
Nicole Christopher at 212-601-8279 or nchristopher@porternovelli.com
Sherry Marks at 212-601-8385 or smarks@porternovelli.com


'"/>

Contact: Nicole Christopher
nchristopher@porternovelli.com
212-601-8279
Porter Novelli
4-Dec-2002


Page: 1

Related biology news :

1. Hemophilia trials, other studies may herald successful gene therapies for human diseases
2. Successful Hemophilia B Gene Therapy In Dogs May Justify Human Experiments
3. Avigens Gene Therapy Approach Shows Promise In Treating Hemophilia B With Single Intramuscular Administration
4. Targeted therapy knocks out pediatric brain cancer in mice
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Columbia research to examine gene influence on severity of peridontal disease, therapy response
7. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
8. The search for a kinder, gentler chemotherapy
9. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
10. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
11. Gene changes linked to increased eye pressure may have implications for glaucoma therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/2/2020)... ... March 02, 2020 , ... ... 71st annual Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy ( Pittcon 2020 ... Pittcon is the world’s leading annual conference and exposition on laboratory science, attracting ...
(Date:2/28/2020)... ... February 27, 2020 , ... An upcoming episode of ... for maladies, such as Inflammatory Bowel Disease (IBD), specifically Crohn’s Disease (Crohn’s), and ... on a novel platform developed by Deka Biosciences, Inc. (Deka Biosciences), that will ...
(Date:2/28/2020)... ... February 28, 2020 , ... Regen ... orders. This includes all available stem cell and exosome biologics. , Regen Suppliers ... Exosome Biologics, PRP kits, adipose kits, PDO thread lifts and more. The ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... , ... February 20, 2020 , ... ... supply chain transparency and reassuring consumers that what’s listed on an ingredient panel ... ingredients, Nutrition21 has introduced this solution with the adoption of CertainT, which is ...
(Date:2/19/2020)... ... February 18, 2020 , ... Shoreline Biome, ... the strain level, recently unveiled a novel DNA isolation product. , Shoreline Rapid ... of high molecular weight (HMW) single-stranded DNA (ssDNA) in excess of 40 kB ...
(Date:2/13/2020)... , ... February 12, 2020 , ... ... pharmacovigilance (PV) solutions and services, is adopting Veeva Vault Safety™ as ... a requirement for fast assessment of data, processing of safety information such as ...
(Date:2/10/2020)... ... ... R3 Medical Training announced it is now registering for its next Comprehensive ... is hands on involving real patients and stem cell biologics, with every attendee receiving ... Training Course has received rave reviews from attendees, who love the hands on nature ...
Breaking Biology Technology:
Cached News: